Biogen Inc (BIIB)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$173.94

Buy

$175.76

arrow-up$1.64 (+0.94%)

Prices updated at 15 Dec 2025, 14:00 EST

Prices minimum 15 mins delay

Prices in USD

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

NASDAQ

-0.59%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	9,836m	9,676m
	7,302m	7,366m
	1,831m	2,219m
	18.62	22.93
	1,161m	1,632m
	2,039m	2,830m
Sales, General and administrative	2,550m	2,404m
Interest expenses	247m	250m
Provision for income taxes	135m	274m
Operating expenses	5,471m	5,147m
Income before taxes	1,297m	1,906m
Net income available to common shareholders	1,161m	1,632m
	8.02	11.21
Net interest income	30m	-183m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	7.97	11.18
Free cash flow per share	7.0534	12.1144
Book value/share	99.9572	112.2631
Debt equity ratio	0.485709	0.292038

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	6,859m	7,457m
Current liabilities	3,434m	5,529m
Total capital	21,588m	21,263m
Total debt	7,338m	6,630m
Total equity	14,799m	16,716m
Total non current liabilities	-	-
Loans	6,788m	4,547m
Total assets	26,845m	28,049m
Total liabilities	-	-
Cash and cash equivalents	1,050m	2,375m
Common stock	145m	146m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	3,419m	1,050m
Cash dividends paid	-	-
	1,236m	2,516m
Investments (gains) losses	-4,101m	-799m
	1,050m	2,375m
Net income	-	-
	1,547m	2,876m
	-311m	-360m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.